COVID-19 in Post-Acute and Long-Term Care: Challenges and Opportunities
COVID-19, Long-term symptoms, Pharmacologic treatment, Post-acute and long-term care, Prevention and control strategies, Supportive care
The emergence of the coronavirus pandemic in early 2020 has challenged health care systems in the USA and globally and overwhelmed US nursing and assisted living facilities. As of midyear 2022, the SARS-Covid-2 virus has caused more than 152,000 US deaths among nursing home residents and over 2300 confirmed deaths among nursing home staff by early 2021. Over 1.3 million confirmed cases have occurred amid residents and staff. Weekly COVID-19 cases in US nursing facilities peaked in late 2020 and deaths in early 2021. Despite the headway made in hospital care, COVID-19 vaccinations, the development of antivirals, and the availability of monoclonal antibodies, the continued emergence of COVID-19 variants and subvariants that are more infectious and less prevented by the original COVID-19 vaccine continue present ongoing challenges in the prevention and treatment of COVID-19. As of September 2022, a bivalent COVID-19 vaccine has become available.
Pandya, Naushira; Hames, Elizabeth; and Winn, Peter, "COVID-19 in Post-Acute and Long-Term Care: Challenges and Opportunities" (2023). HPD Articles. 481.
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG